Injection practices among medical practitioners working at private clinics in Karachi. Shair Muhammad Hazara BSc N, MSBE Nursing Instructor College of.

Slides:



Advertisements
Similar presentations
Injection Safety in EPI: More than just AD Syringes and Safety Boxes World Health Organization HTP/V&B/EPI.
Advertisements

 Are transmissible in health care settings  Can produce chronic infection  Are often carried by persons unaware of their infection Bloodborne viruses.
Hepatitis B and Hepatitis B Vaccine Epidemiology and Prevention of Vaccine- Preventable Diseases National Center for Immunization and Respiratory Diseases.
Injection Practices in Mongolia Results and Outcomes of the Rapid Assessment of Injection Practices Dr G. Soyolgerel Dr G. Soyolgerel Ministry of Health.
Hepatitis C In Alaska’s Department of Corrections
An executive summary for tackling global challenges 1 Injection Safety in the Perspective of the Global Challenges Survey by Global2015.
Sol-Millennium MVP Injection Solution Contributor to Safety Injection In Immunization Service.
Andrew Gray March 10, Poverty Basic nutrition and clean water Shelter Education Basic medical care (public health) Lack of access.
SIGN Pakistan Dr. Arshad Altaf. Objectives of the Presentation zOverview of burden of disease in Pakistan because of unsafe injection practices zPresent.
Afghanistan’s Present IDUs-HIV/AIDS Situation and future action plan Dr.Saifur-Rehman NACP Director April,11,2007 Islamic Republic of Afghanistan Ministry.
SIGN Rapid Assessment Survey Northern Areas, Pakistan Lubna Samad, MRCS, FCPS Pediatric Surgeon National Institute of Child Health.
Work Related Injuries among Hospital Workers in Iringa, Tanzania 2013 Godbless Lucas – FELTP Tanzania AFENET Conference November 2013.
A Webinar Hosted by The National Harm Reduction Coalition The National Black Leadership Commission on AIDS The Coalition for Positive Health Empowerment.
Page 1 Factors associated with glycemic control in type 2 diabetes patients at Primary Care Unit, Pathumrat District, Thailand Factors associated with.
DRUG-RESISTANT TB in SOUTH AFRICA: Issues & Response _ ______ _____ _ ______ _____ ___ __ __ __ __ __ _______ ___ ________ ___ _______ _________ __ _____.
Kenya Field Epidemiology and Laboratory Training Program (KFELTP)
Adult Viral Hepatitis Update Roxanne Ereth, MPH, BS Hepatitis C Program Manager Adult Viral Hepatitis Prevention Coordinator.
Perceived HIV risks, types of sexually transmitted diseases, and discordant infection status among low-tier female sex workers in China (Roundtable Presentation)
Safer Needle Devices: Protecting Health Care Workers.
Wyoming Department of Health Communicable Diseases
Harold S. Margolis, M.D. Division of Viral Hepatitis
1 Dr.I.A.Joshua 2 Dr JG Makama 3 Dr A Oyemecho 1 Department of Community/ 2 Department of Surgery Kaduna State University, Kaduna, Nigeria 3 Department.
LOKENDRA YADAV IETE M.NO-SD TEN FACTS ABOUT PATIENT SAFETY.
World Hepatitis Day 2013, 29 th July Establishing a framework for better data collection and surveillance of Hepatitis in South Africa N. Prabdial-Sing.
Prevention and Control of Viral Hepatitis Infection: WHO Framework for Global Action Prevention and Control of Viral Hepatitis Infection: WHO Framework.
A Cluster of Hepatitis C among Rural, Young Adults – Illinois, 2012 Julia Howland, MPH CPH CDC/CSTE Applied Epidemiology Fellow Illinois Department of.
FHM TRAINING TOOLS This training presentation is part of FHM’s commitment to creating and keeping safe workplaces. Be sure to check out all the training.
Safe Immunization Practices and Prevention of Hepatitis B and C Susan Mackay Behaviour Change Project Safe Injection Global Network.
Overview of Hepatitis B, C, and D Epidemiology in Eastern Europe and the Newly Independent States Michael O. Favorov MD, Ph.D., D.Sc. CDC Central Asia.
1 HIV and AIDS Data Hub for Asia-Pacific Review in slides Pakistan.
Prevalence of Hepatitis B infection in married women of child bearing age in District Islamabad Dr. Najma Javeed Awan Senior Medical Officer Pakistan Medical.
HIV and AIDS Data Hub for Asia-Pacific HIV and AIDS Data Hub for Asia-Pacific Review in slides China 1.
TEMPLATE DESIGN © PRACTICE OF UNIVERSAL PRECAUTIONS AND OCCUPATIONAL EXPOSURES AMONG HEALTH CARE WORKERS Tuteja A, Chintamani,
Focus Area 17: Medical Product Safety Progress Review November 5, 2003.
CURRENT HEALTH PROBLEMS IN STUDENT'S HOME SOUNTRIES HEPATITIS B IN MALAYSIA MOHD ZHARIF ABD HAMID AMINUDDIN BAKI AMRAN.
A Pilot Intervention To Improve Injection Practices In The Informal Private Sector in Karachi, Pakistan Mubina Agboatwalla (1) Yvan Hutin (2) Steve Luby.
Improvement of Injection Safety in Burkina Faso, JF. Aguilera, J. Fitzner, A. Yaméogo, Y. Hutin.
Estimating the Global Burden of HCV Infections Associated with Unsafe Health Care Injections Anja Hauri 1, Gregory Armstrong, 2 Yvan Hutin 1 1. WHO Headquarters,
Vaccines & Biologicals (V&B) Cost-effectiveness of safe injection policies: Study rationale and proposed methodology Ulla Kou, WHO SIGN meeting in New.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Pakistan Last updated: January 2016.
"Epidemiological Features of Rotavirus Infection among children below 5 years old in Jordan, Rationale for Vaccine Introduction,2015" Kareman Juma`ah Al-Zain.
Lessons Learned and Novel Investigation Techniques in Response to a Large Community Outbreak of HIV-1 infection Philip J. Peters MD HIV Testing and Biomedical.
HIV in India David S. Hausner American Embassy School 8 th Grade Population Project 24 February 2012.
HIV and AIDS Data Hub for Asia-Pacific Review in slides India Last updated: March 2016.
From evidence to commitment to action: implementing HIV prevention measures in prisons in Ukraine XVI International AIDS Conference Toronto, 15 August.
HEALTH CARE WORKER RISK OF BBP TRANSMISSION: U.S. PUBLIC HEALTH SUCCESS STORY Elayne K. Phillips, BSN, MPH, PhD Janine Jagger, MPH, PhD International Healthcare.
Abstract Problem Statement: As in many former socialist economies, anecdotal reports suggested that injections were overused to administer medications.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Pakistan.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Pakistan Last updated: November 2014.
United States / Turkey HIV/AIDS. What is HIV? HIV is the Human Immunodeficiency Virus It is the virus that causes AIDS AIDS destroys the human immune.
HBV. Overview of the Epidemiology of Hepatotropic Viruses.
Bloodborne viral and sexually transmissible infections in Aboriginal and Torres Strait Islander people: Annual Surveillance Report 2016.
3rd International HIV/Viral Hepatitis Co-Infection Meeting HIV/Viral Hepatitis: Improving Diagnosis, Antiviral Therapy and Access Sunday, 17 July.
Injecting Drug Users and HIV/AIDS in Pakistan
Bhutan Last updated: September 2016.
Assessment of Injection Drug Use Based on Diagnostic Codes in Administrative Datasets M Kuo 1, NZ Janjua 1,2, AYW Yu 1, N Islam 1,2, H Samji 1, JA Buxton.
Singapore Last updated: November 2016.
Enhanced Pharmacy Provision in Edinburgh:
Pakistan Last updated: July 2015.
Hepatitis C Incidence and Prevalence in the U.S.
World Health Organization
Daffodil International University (DIU), Dhaka Bangladesh
Higher Prevalence of HbsAg among Blood Donors at a tertiary care center in greater Gwalior: A 5years study ( TTI-12 : D-1182 ) Dr. Anita Arya, Dr. Sachin.
Bloodborne viral and sexually transmissible infections in Aboriginal and Torres Strait Islander people Annual Surveillance Report 2017.
Bhutan.
Blood borne viral hepatitis action in Wales
Bhutan Last updated: July 2018.
Fig. 6.9.
Share your thoughts on this presentation with #IAS2019
Presentation transcript:

Injection practices among medical practitioners working at private clinics in Karachi. Shair Muhammad Hazara BSc N, MSBE Nursing Instructor College of Nursing, PIMS, Islamabad Acknowledgement Muhammad Tahir Yousafzai 1

Introduction  Injection therapy was first introduced to the developing world with the mass campaigns against yaws and kala-azar in the 1920s, – and became widespread after the Second World War following the introduction of penicillin [1].  WHO estimate 95 % injections are used for curative care, 3% for immunization, 1% injectable contraceptive and 1% blood injection and blood products [2].  Injection unnecessary and unsafe practices results in a major route of transmission for hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV) [3]. 1.Kermode, M., et al., Safer injections, fewer infections: injection safety in rural north India. Trop Med Int Health, (5): p WHO and Factsheet N° 23; Injection safety. Revise Yan, Y.W., et al., Prevalence of injections and knowledge of safe injections among rural residents in Central China. Singapore Med J, (8): p

 Other complications of unsafe injections include infection with HIV, abscesses, septicemia, malaria, and viral hemorrhagic fevers [1, 5].  Different health care providers e.g. quacks, paramedics and TBA are prefer the use of injection as compare of oral medications.  Therapeutic injections in Sindh are mostly provided at general practitioner (GP) clinics (63%) – and are most frequently administered by unqualified drug dispensers (75%) at these clinics*. Introduction * Naveed Z. Janjua, Aamir J. Khan, Arshad Altaf. (2006). Canadian International Development Agency (CIDA). 3

Global data  16 billion injections are given annually*  Each year, unsafe injection practices cause * 21 million hepatitis B infections (33% of new cases) 2 million hepatitis C infections (42% of new cases) HIV/AIDS infections (2% of new cases)  Up to 70% of injections are given with reused syringes and needles in the developing world  Over 70% of injections are unnecessary in some regions * Hutin et al,2003; Hauri et al,2004 4

Global data Disease burden Unsafe injection practices Number *% * Hepatitis B virus 15 million25% Hepatitis C Virus1 million8% HIV Infection340,00014% Bacteraemia worldwide3 million7% Injection site abscesses850, DALYs28 million---- * SIGN 2010 Annual Meeting of the Safe Injection Global Network. 9 to 11 November

Global data  Each year unsafe injections cause an estimated 1.3 million early deaths [1].  A loss of 26 millions years of life [1].  An annual burden of US $ 600 million in direct medical cost [2].  In some developing countries, over 90% of patients visiting a PHC provider receive at least one injection [3].  An average of 3.4 injections per person per year [3]. 1.Altaf, A., N.Z. Janjua, and Y. Hutin, The cost of unsafe injections in Pakistan and challenges for prevention program. J Coll Physicians Surg Pak, (9): p Miller, M.A. and E. Pisani, The cost of unsafe injections. Bull World Health Organ, (10): p Safe Injection Global Network (SIGN) report

Pakistan data  Pakistan is a populated country with 185 million at ranked 6 th number among world population [1].  SIGN, Pakistan has the highest frequency of injections worldwide range of 8.2 to 13.6 per person/ year [2].  Average price of an injection (not the complete prescription) is Rs (0.34 US dollars) [3].  Pakistan would cost 92 million US dollars each year with a high proportion for safe and appropriate use of injection. 1.PRB, World Population Data Sheet. Population Reference Bureau, Safe Injection Global Network (SIGN) report Altaf, A., N.Z. Janjua, and Y. Hutin, The cost of unsafe injections in Pakistan and challenges for prevention program. J Coll Physicians Surg Pak, (9): p

 Hepatitis C infected were 8.2 times more likely to receive more than 5 injections [1]  93% of injections in the private sector are unnecessary [2]  75%-94% of injection equipment in the private sector is reused [2]  12% of injections in the government sector are reused [2]  53% of new hepatitis B infections are attributable to therapeutic injection reuse [2]. Pakistan data 1.Luby SP, et al. The relationship between therapeutic injections and high prevalence of hepatitis C infection in Hafizabad, Pakistan. Epidemiol Infect Dec;119(3): Ministry of Health Survey 2002 : Pakistan Fact List 8

 Odds of having infection (relative to those who have received injections)  6.5 times higher for hepatitis C if 10 injections received in past 1 year [1].  6.7 times higher for hepatitis B if 01 injections received in past 6 months [1]. Pakistan data 1.Epidemiological studies from

Methods  STUDY DESIGN: A Cross Sectional Study  SETTING: Slum areas consisting of Majeed colony, Bilal colony, Mulimabad colony, Muzafarabad colony and Sherpao colony of Landhi town, Karachi.  DURATION OF STUDY: The study was carried out from May 2006 to July

Methods  Whole population of one Union Council o Total 407 private clinics located o 10 Practitioners exclude < 1 year Experience o 317 / 397 (80%)  Inclusion criteria o > 1 year experience o Located within boundary of UC Landhi  Exclusion criteria o < 1 year experience o Located out side boundary of UC landhi 11

Methods  Data Collection o A structure questionnaire  Validity of Tool o Pilot tested on 20 medical practitioners (working outside area). o Inconsistency or ambiguities (remove before administration) o Revisited to the medical practitioners after one week, refill the questionnaire. 12

Results 13 Table 1: Descriptive characteristics of medical practitioners in Karachi, Pakistan (N=317)

14 Results Table 1: Descriptive characteristics of medical practitioners in Karachi, Pakistan (N=317)

Result 15

Result 16 Table 3 : Prevalence of at least one sharp injury in the last one year among practitioners at clinics in landhi town, Karachi. * 95% Confidence Interval

Result 17 Table 4: Determinants of sharp injury among medical practitioners working in clinics at landhi town, Karachi.

Result 18 Fig 1. Odds ratio of sharp injuries among medical practitioners across different categories of work experience in slum area of Karachi

Limitation  Self reported data  Social desirability bias  Imperfect recall bias (SI in last one year) 19

Conclusion  Medical practitioners are at high risk of Blood borne infections  High prevalence of SI due unsafe injection practice  Awareness at large scale level to enhance Safe injection practice e.g. One hand injection technique  Vaccination of Medical Practitioners 20

21

22 Source: Thank You